首页 产品目录 分子砌块 按官能团 酮类 4b-羟基-2-(2-羟基丙-2-基)-12b,12c-二甲基-5,6,6a,7,12,12b,12c,13,14,14a-十氢-2H-色烯并[5',6':6,7]茚并[1,2-b]吲哚-3(4bH)-酮

4b-羟基-2-(2-羟基丙-2-基)-12b,12c-二甲基-5,6,6a,7,12,12b,12c,13,14,14a-十氢-2H-色烯并[5',6':6,7]茚并[1,2-b]吲哚-3(4bH)-酮

4b-hydroxy-2-(2-hydroxypropan-2-yl)-12b,12c-dimethyl-5,6,6a,7,12,12b,12c,13,14,14a-decahydro-2H-chromeno[5',6':6,7]indeno[1,2-b]indol-3(4bH)-one

产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量
1mg 95% 询价
- +
5mg 95% 询价
- +
10mg 95% 询价
- +
晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

57186-25-1

中文名称

4b-羟基-2-(2-羟基丙-2-基)-12b,12c-二甲基-5,6,6a,7,12,12b,12c,13,14,14a-十氢-2H-色烯并[5',6':6,7]茚并[1,2-b]吲哚-3(4bH)-酮

英文名称

4b-hydroxy-2-(2-hydroxypropan-2-yl)-12b,12c-dimethyl-5,6,6a,7,12,12b,12c,13,14,14a-decahydro-2H-chromeno[5',6':6,7]indeno[1,2-b]indol-3(4bH)-one

别名

Bio2_000627 | SCHEMBL361232 | BRD-K38251852-001-02-5 | NCGC00025342-05 | Bio1_001106 | IDI1_033897 | paxillin | Q10860377 | UNII-3T9U9Z96L7 | (2R,4bS,6aS,12bS,12cR,14aS)-5,6,6a, 7,12,12b,12c,13,14,14a-Decahydro-4b-hydroxy-2-(1-h ydroxy-1-methylethyl)-12b,

标准英文名

4b-hydroxy-2-(2-hydroxypropan-2-yl)-12b,12c-dimethyl-5,6,6a,7,12,12b,12c,13,14,14a-decahydro-2H-chromeno[5',6':6,7]indeno[1,2-b]indol-3(4bH)-one

分子式

C27H33NO4

分子量

435.56

精确分子量

435.24

SMILES

CC(C)(O)C1OC2CCC3(C)C(O)(CCC4CC5=C(NC6=CC=CC=C56)C43C)C2=CC1=O

标准SMILES

CC(C)(O)C1OC2CCC3(C)C(O)(CCC4CC5=C(NC6=CC=CC=C56)C34C)C2=CC1=O

用途

Paxilline is a specific blocker of BK channels, used to alleviate absence epilepsy and motor disorders caused by the BK-D434G gain-of-function mutation; it exhibits significant anticonvulsant activity; additionally, it inhibits sarco/endoplasmic reticulum Ca²⁺-ATPase (SERCA) with IC₅₀ values ranging from 5 to 50 μM across different SERCA isoforms.

InChIKey

ACNHBCIZLNNLRS-UHFFFAOYSA-N

安全信息

SureRoute逆合成路线

1.  57186-25-1 逆合成路线 1

—
—
—
—
ACTLOF921
57186-25-1
来源: SureRoute

2.  57186-25-1 逆合成路线 2

—
—
—
—
ACTLOF921
57186-25-1
来源: SureRoute

3.  57186-25-1 逆合成路线 3

—
—
ACTLOF921
57186-25-1
来源: SureRoute
评论 0
我是晶智Agent,
您的化学小助手